Literature DB >> 21252957

Treatment of postoperative uveal effusion in a nanophthalmic patient with posterior sub-Tenon's triamcinolone (PSTT).

E Gosse, A Gittos, J Lochhead.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21252957      PMCID： PMC3171233          DOI： 10.1038/eye.2010.219

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  [Intravitreal triamcinolone and bevacizumab injections for alternative treatment of nanophthalmic uveal effusion syndrome].

Authors:  F Rüfer; M A Varde; J Roider
Journal:  Klin Monbl Augenheilkd       Date:  2008-06       Impact factor: 0.700

2.  Management of glaucoma in patients with nanophthalmos.

Authors:  I S Yalvac; B Satana; G Ozkan; U Eksioglu; S Duman
Journal:  Eye (Lond)       Date:  2007-02-09       Impact factor: 3.775

3.  Sclerotomy in uveal effusion syndrome.

Authors:  J Faulborn; H Kölli
Journal:  Retina       Date:  1999       Impact factor: 4.256

4.  Phacoemulsification in patients with nanophthalmos.

Authors:  Erdal Yuzbasioglu; Ozgur Artunay; Ahmet Agachan; Harun Bilen
Journal:  Can J Ophthalmol       Date:  2009-10       Impact factor: 1.882

5.  Cataract surgery in patients with nanophthalmos: results and complications.

Authors:  Wayne Wu; Daniel G Dawson; Alan Sugar; Susan G Elner; Kathy A Meyer; Jesse B McKey; Sayoko E Moroi
Journal:  J Cataract Refract Surg       Date:  2004-03       Impact factor: 3.351
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.